Even before the onset of the COVID-19 pandemic in 2020, mental disorders were leading causes of ill health globally. The pandemic has exacerbated the situation.
According to an analysis published in The Lancet, the pandemic has led to a stark rise in depressive and anxiety disorders globally, adding 53.2 million cases of anxiety and 76.2 million cases of major depressive disorders (MDD). Before the pandemic, 193 million people were diagnosed with MDD and after the pandemic, the figure had increased to 246 million.
Studies have shown that psilocybin, the hallucinogenic chemical in Magic Mushrooms Canada, can be effective for the treatment of depression. One 2020 study published in JAMA Psychiatry led by researchers from John Hopkins Medicine found that two doses of psilocybin had substantial rapid and lasting antidepressant effects for patients with MMD. The psilocybin administration was augmented with supported psychotherapy.
It’s common knowledge that traditional antidepressants don’t work for many people and have adverse effects, one being the blunting of emotions. Maybe it’s time to investigate the advantages of taking magic mushrooms for depression. Maybe it’s time to investigate the advantages of taking magic mushrooms for depression and overall the idea of psychedelic therapies and clinics.
One of the issues with traditional antidepressants is the time it takes before it starts to work. Oftentimes patients just give up and stop taking the medication. In contrast, magic mushrooms work fast.
In one study conducted at the Centre for Psychedelic Research at Imperial College London, patients that received psilocybin showed a much more rapid improvement in depression than patients that received the commonly prescribed selective serotonin reuptake inhibitor (SSRI) escitalopram.
Patients who are have major depression, can’t wait for weeks before they start feeling better. In that time, there’s a risk that they might resort to some kind of self-harming behavior.
2. Lasting Results
Studies have shown that treatment with psilocybin has long lasting results. In one study, just two doses, brought relief from depression for five weeks. Research demonstrates that relief lasted up to five weeks after two doses of psilocybin.
A study in the Journal of Psychopharmacology demonstrated a single psilocybin dose administered to cancer patients still had antidepressant effects 5 years after they received the psilocybin.
There is no traditional antidepressant that you can take in a single dose to relief depression.
3. No blunting of emotions
People who have taken magic mushrooms Canada don’t report that their emotions were blunted afterwards. In fact, the experience seems to put them in touch with their emotions.
The fact that a mushroom trip goes hand in hand with psychotherapy that offers the opportunity to integrate the mystical experience, help people to work through their emotions.
4. No or few side effects
Psilocybin use typically have few or no side effects, and it lacks the side effects often associated with common antidepressant medications, like weight gain, loss of sexual desire, lethargy, insomnia and constipation, among others.
5. Mystical experience
Taking magic mushrooms can lead to life-altering mystical experiences. In many cases, these experiences didn’t only address a person’s problem, but completely changed their attitude about life and their place in it. These profound experiences seem to affect people deeply and bring about positive changes in their live.
Of course, not everyone who takes magic mushrooms will be so lucky, but if you decide to try psilocybin- assisted psychotherapy you at least give yourself the opportunity to peer deeply into the unknown and come out on the other side wiser.
6. Hope for Treatment-Resistant Depression
A person is diagnosed with treatment-resistant depression when none of the acknowledged treatments show any effect. These people have usually tried different medications, traditional and alternative therapies to no effect.
Studies at the Centre for Psychedelic Research at Imperial College London, show that psilocybin is effective for patients with treatment-resistant depression. Dr. Robin Carhart-Harris, Head of the Centre for Psychedelic Research at Imperial, said: “These latest findings build on our previous research testing psilocybin therapy for treatment-resistant depression, and offer the most compelling evidence yet to support efforts towards licensing psilocybin therapy as a regulated mental health intervention.’’
Keep in mind that the use of magic mushrooms Canada is illegal, and doctors and psychiatrists don’t recommend self-medicating with magic mushrooms. If studies keep confirming positive results, we may have a future where treating depression with psilocybin-assisted psychotherapy will be common practice.